Kemp B. Cease

4.5k total citations · 2 hit papers
61 papers, 3.7k citations indexed

About

Kemp B. Cease is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kemp B. Cease has authored 61 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kemp B. Cease's work include Lung Cancer Diagnosis and Treatment (15 papers), vaccines and immunoinformatics approaches (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Kemp B. Cease is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), vaccines and immunoinformatics approaches (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Kemp B. Cease collaborates with scholars based in United States, China and France. Kemp B. Cease's co-authors include Jay A. Berzofsky, James Cornette, Charles DeLisi, Hanah Margalit, John L. Spouge, Jon Oscherwitz, Sara Brett, Hiroaki Takahashi, Anne Hosmalin and Ronald N. Germain and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Kemp B. Cease

58 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins

1987 523 citations James Cornette, Kemp B. Cease et al. profile →
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells

2013 409 citations Yuumi Nakamura, Jon Oscherwitz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kemp B. Cease United States	26	1.6k	1.3k	780	708	465	61	3.7k
Oleg Chertov United States	33	3.1k 1.9×	4.0k 3.1×	329 0.4×	466 0.7×	643 1.4×	68	7.9k
Giampietro Corradin Switzerland	44	3.0k 1.9×	3.5k 2.7×	984 1.3×	616 0.9×	924 2.0×	164	7.4k
Gerald Nakamura United States	30	1.3k 0.8×	1.2k 1.0×	798 1.0×	1.8k 2.5×	880 1.9×	45	3.6k
Yvonne Paterson United States	50	2.7k 1.6×	3.4k 2.6×	734 0.9×	264 0.4×	772 1.7×	166	7.7k
Mi‐Hua Tao Taiwan	36	1.8k 1.1×	2.0k 1.6×	989 1.3×	181 0.3×	1.0k 2.2×	117	5.0k
Sam Li United States	27	2.0k 1.2×	1.1k 0.9×	190 0.2×	828 1.2×	401 0.9×	58	4.2k
Ronald C. Kennedy United States	39	1.5k 0.9×	1.8k 1.4×	882 1.1×	1.1k 1.5×	862 1.9×	161	4.7k
Sigvard Olofsson Sweden	39	1.6k 1.0×	1.1k 0.9×	557 0.7×	936 1.3×	2.1k 4.4×	123	4.2k
Pedro A. Reche Spain	36	2.7k 1.7×	2.9k 2.2×	816 1.0×	270 0.4×	803 1.7×	110	6.8k
William H. Hildebrand United States	44	2.3k 1.4×	4.7k 3.6×	707 0.9×	828 1.2×	650 1.4×	156	6.5k

Countries citing papers authored by Kemp B. Cease

Since Specialization

Citations

This map shows the geographic impact of Kemp B. Cease's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemp B. Cease with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemp B. Cease more than expected).

Fields of papers citing papers by Kemp B. Cease

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemp B. Cease. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemp B. Cease. The network helps show where Kemp B. Cease may publish in the future.

Co-authorship network of co-authors of Kemp B. Cease

This figure shows the co-authorship network connecting the top 25 collaborators of Kemp B. Cease. A scholar is included among the top collaborators of Kemp B. Cease based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemp B. Cease. Kemp B. Cease is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Feng‐Ming, Randall K. Ten Haken, Matthew J. Schipper, et al.. (2017). Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer. PMC. 9 indexed citations

Qin, Angel, et al.. (2017). Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(1). 228–228. 1 indexed citations

Oscherwitz, Jon & Kemp B. Cease. (2015). Identification and Validation of a Linear Protective Neutralizing Epitope in the β-Pore Domain of Alpha Toxin. PLoS ONE. 10(1). e0116882–e0116882. 12 indexed citations

Oscherwitz, Jon, Conrad P. Quinn, & Kemp B. Cease. (2015). Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen. Vaccine. 33(20). 2342–2346. 8 indexed citations

Oscherwitz, Jon, et al.. (2014). Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax. Vaccine. 33(3). 430–436. 5 indexed citations

Ramnath, Nithya, Stephanie Daignault‐Newton, Grace K. Dy, et al.. (2013). A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 71(5). 1173–1182. 23 indexed citations

Nakamura, Yuumi, Jon Oscherwitz, Kemp B. Cease, et al.. (2013). Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature. 503(7476). 397–401. 409 indexed citations breakdown →

Oscherwitz, Jon, Thomas Gribbin, & Kemp B. Cease. (2010). A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo☆. Molecular Immunology. 47(7-8). 1484–1491. 6 indexed citations

Oscherwitz, Jon, et al.. (2009). A Heterologous Helper T-Cell Epitope Enhances the Immunogenicity of a Multiple-Antigenic-Peptide Vaccine Targeting the Cryptic Loop-Neutralizing Determinant ofBacillus anthracisProtective Antigen. Infection and Immunity. 77(12). 5509–5518. 20 indexed citations

10.

Oscherwitz, Jon, et al.. (2008). Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors. Molecular Therapy. 17(2). 373–379. 16 indexed citations

11.

Oscherwitz, Jon, et al.. (2005). Low-dose intraperitoneal Freund's adjuvant: Toxicity and immunogenicity in mice using an immunogen targeting amyloid-β peptide. Vaccine. 24(15). 3018–3025. 30 indexed citations

12.

Oscherwitz, Jon, Mary E. Zeigler, Thomas Gribbin, & Kemp B. Cease. (1999). A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein. Vaccine. 17(19). 2392–2399. 14 indexed citations

13.

Cease, Kemp B., et al.. (1994). Optimized PCR using Vent polymerase.. Genome Research. 3(5). 298–300. 6 indexed citations

14.

Kaldjian, Eric, Gwo-Hsiao Chen, & Kemp B. Cease. (1992). Enhancement of lymphocyte proliferation assays by use of serum-free medium. Journal of Immunological Methods. 147(2). 189–195. 26 indexed citations

15.

Bitar, Khalil N., Mark Kaminski, Nabil Hailat, Kemp B. Cease, & John R. Strahler. (1991). HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin. Biochemical and Biophysical Research Communications. 181(3). 1192–1200. 109 indexed citations

16.

Cease, Kemp B.. (1990). Peptide Component Vaccine Engineering: Targeting the AIDS Virus. International Reviews of Immunology. 7(1). 85–107. 18 indexed citations

17.

Cease, Kemp B., Richard A. Houghten, Scott D. Putney, et al.. (1989). T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction. International Immunology. 1(4). 409–415. 63 indexed citations

18.

Kojima, M., Kemp B. Cease, G K Buckenmeyer, & Jay A. Berzofsky. (1988). Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells.. The Journal of Experimental Medicine. 167(3). 1100–1113. 37 indexed citations

19.

Berzofsky, Jay A., Armand Bensussan, Kemp B. Cease, et al.. (1988). Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature. 334(6184). 706–708. 125 indexed citations

20.

Berzofsky, Jay A., Kemp B. Cease, James Cornette, et al.. (1987). Protein Antigenic Structures Recognized by T Cells; Potential Applications to Vaccine Design. Immunological Reviews. 98(1). 9–52. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact